EpiVax's Grant - XVI Round

EpiVax raised a round of funding on July 14, 2009. Investors include National Institutes of Health.

EpiVax, is a privately held biotechnology company focused on the development of vaccines and immunotherapies for infectious diseases, autoimmunity and cancer. The immunoinformatics team at EpiVax has …

Articles about EpiVax's Grant - XVI Round: